Henry Kitchener
| Professor Henry Kitchener MD FRCOG FRCS(Glas) FMedSci | |
|---|---|
|
Professor Kitchener, December 2009 | |
| Born |
Henry Charles Kitchener 1 July 1951 Glasgow, Scotland |
| Residence | England |
| Nationality | British |
| Fields |
Gynaecology Oncology Virology |
| Institutions | University of Manchester |
| Alma mater | University of Glasgow |
| Known for |
Human Papillomavirus Cervical Cancer Vaccines |
| Spouse | Valerie Kitchener |
Professor Henry Kitchener, MD FRCOG FRCS(Glas) FMedSci, is a leading British expert in gynaecological oncology, based at the University of Manchester.[1] He is a fellow of the Academy of Medical Sciences.[2]
Research
Prof. Kitchener's work has centred on research into Human Papillomavirus ("HPV").[3]
He is an advocate of HPV testing and cervical screening for women,[4][5] and has led various trials for HPV vaccines, including a cervical screening of 25,000 women.[6]
His research has been funded by a number of groups, including the Medical Research Council, Cancer Research UK, Wellbeing of Women, and other national and local charities.[6]
Career
- MRCOG (1980)
- Florence and William Blair-Bell research fellow, University of Glasgow (1980–1982)
- Lecturer in obstetrics and gynaecology, University of Singapore (1983–1984)
- William Blair-Bell memorial lecturer, Royal College of Obstetricians and Gynaecologists (1985)
- Consultant obstetrician and gynaecologist, University of Aberdeen (1988–1996)
- FRCS(Glas) (1989)
- FRCOG (1994)
- Professor of gynaecological oncology, University of Manchester (1996–present)
- Vice-President of the British Society for Colposcopy and Cervical Pathology (1997–1999)
- President of the British Society for Colposcopy and Cervical Pathology (2000–2003)
- Fellow of the Academy of Medical Sciences (2007)
- Chair of the Gynaecological Cancer InterGroup (2008)
Publications
Professor Kitchener is the author and co-author of numerous peer-reviewed journal articles and books including:
- (2010) The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report. International journal of gynecological cancer, Official Journal of the International Gynecological Cancer Society, 20(6), 1092-100.
- (2008) Informing adolescents about human papillomavirus vaccination: what will parents allow? Vaccine, 26( 18),
- (2006) HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. British Journal of Cancer, 95( 1), 56-61.
- (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART Study. The Lancet.
References
This article is issued from Wikipedia - version of the Saturday, May 09, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.